Inga A - Search Results

1

Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.

Inga A, Storici F, Darden TA, Resnick MA. Inga A, et al. Mol Cell Biol. 2002 Dec;22(24):8612-25. doi: 10.1128/MCB.22.24.8612-8625.2002. Mol Cell Biol. 2002. PMID: 12446780 Free PMC article.

2

p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay.

Inga A, Monti P, Fronza G, Darden T, Resnick MA. Inga A, et al. Oncogene. 2001 Jan 25;20(4):501-13. doi: 10.1038/sj.onc.1204116. Oncogene. 2001. PMID: 11313981

3

Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.

Inga A, Resnick MA. Inga A, et al. Oncogene. 2001 Jun 7;20(26):3409-19. doi: 10.1038/sj.onc.1204457. Oncogene. 2001. PMID: 11423991

4

p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.

Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R, Fronza G. Campomenosi P, et al. Among authors: inga a. Oncogene. 2001 Jun 14;20(27):3573-9. doi: 10.1038/sj.onc.1204468. Oncogene. 2001. PMID: 11429705

5

Tumour p53 mutations exhibit promoter selective dominance over wild type p53.

Monti P, Campomenosi P, Ciribilli Y, Iannone R, Inga A, Abbondandolo A, Resnick MA, Fronza G. Monti P, et al. Among authors: inga a. Oncogene. 2002 Mar 7;21(11):1641-8. doi: 10.1038/sj.onc.1205250. Oncogene. 2002. PMID: 11896595

6

A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions.

Inga A, Nahari D, Velasco-Miguel S, Friedberg EC, Resnick MA. Inga A, et al. Oncogene. 2002 Aug 22;21(37):5704-15. doi: 10.1038/sj.onc.1205779. Oncogene. 2002. PMID: 12173040

7

Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.

Resnick MA, Inga A. Resnick MA, et al. Among authors: inga a. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9934-9. doi: 10.1073/pnas.1633803100. Epub 2003 Aug 8. Proc Natl Acad Sci U S A. 2003. PMID: 12909720 Free PMC article.

8

Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.

Tomso DJ, Inga A, Menendez D, Pittman GS, Campbell MR, Storici F, Bell DA, Resnick MA. Tomso DJ, et al. Among authors: inga a. Proc Natl Acad Sci U S A. 2005 May 3;102(18):6431-6. doi: 10.1073/pnas.0501721102. Epub 2005 Apr 20. Proc Natl Acad Sci U S A. 2005. PMID: 15843459 Free PMC article.

9

Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system.

Inga A, Reamon-Buettner SM, Borlak J, Resnick MA. Inga A, et al. Hum Mol Genet. 2005 Jul 15;14(14):1965-75. doi: 10.1093/hmg/ddi202. Epub 2005 May 25. Hum Mol Genet. 2005. PMID: 15917268

10

Functional diversity in the gene network controlled by the master regulator p53 in humans.

Resnick MA, Tomso D, Inga A, Menendez D, Bell D. Resnick MA, et al. Among authors: inga a. Cell Cycle. 2005 Aug;4(8):1026-9. doi: 10.4161/cc.4.8.1904. Epub 2005 Aug 7. Cell Cycle. 2005. PMID: 16082206 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters